News

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...
From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...
It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...
In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...
The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...
Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a ...
New Evidation CEO Leslie Olay Wilberforce speaks at a Reuters event earlier this year. Earlier this year, San Francisco-based ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...
After months of preparation and a drip-feed of some of its key features, the UK government has raised the curtain on its new 10-year plan for the NHS. The three over-arching themes are already ...
The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...
Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...